Elacestrant Plus Alpelisib in an ESR1 and PIK3CA Co-mutated and Heavily Pretreated Metastatic Breast Cancer: The First Case for Combination Efficacy and Safety

Preprint

Article

This version is not peer-reviewed.

Downloads

208

Views

229

Comments

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Choose an area of interest and we will send you notifications of new preprints at your preferred frequency.

Disclaimer